What is CAR T-cell therapy? And how it Works?

CAR T-cell therapy is a type of cancer therapy that uses a patient’s own modified white blood cells to kill cancer cells. 

How does CAR T-cell therapy work? 

The procedure begins by collecting blood from the patient with cancer. throughout this process, T cells are alienated and removed from the blood and the remaining blood is returned to the body. 

Chimeric Antigen Receptor or CAR technology and its application on tumor therapy are as below: 

• CAR T in Vitro Assay 
• CAR expression validation 
• CAR-T cell proliferation 

How Long Does The Patient Remain In The Hospital Following CAR T-Cell Therapy? 

Patients typically need to stay in the hospital one to one and one-half weeks after receiving CAR T-cell therapy. measurement lengthwise of stay depends on many factors counting the patient’s response to treatment and the danger for side effects. 

What’s the victory rate of CAR T-cell therapy for lymphoma? 

Over 80 percent of patients who received in clinical trials experienced either a complete or partial response. (A complete response means there were no signs of cancer; partial response means there was some reduction in the extent of cancer.) 

To get quality CAR-T Discovery and CAR-T Solutions contact us now.